Voorhoeve P Mathijs, Agami Reuven
Division of Tumor Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Cancer Cell. 2003 Oct;4(4):311-9. doi: 10.1016/s1535-6108(03)00223-x.
The INK4A locus is often inactivated in human cancer. INK4A encodes for p14ARF and p16INK4A that inhibit growth through p53 and pRb, respectively. We used RNA interference vectors in transformation assays of human primary cells to analyze tumor-suppressive functions. We first show that a concerted inactivation of pRb and p53 is required for transformation. We then demonstrate that loss of p14ARF enhances growth in a p53-dependent manner but has little tumorigenic effect. In contrast, suppression of p16INK4A expression does not affect cellular proliferation but synergizes with p53 loss to accelerate growth and cause transformation. Our results delineate the functions of the human INK4A genes in normal and tumorigenic growth.
INK4A基因座在人类癌症中常常失活。INK4A编码p14ARF和p16INK4A,它们分别通过p53和pRb抑制生长。我们在人类原代细胞的转化实验中使用RNA干扰载体来分析肿瘤抑制功能。我们首先表明,pRb和p53的协同失活是转化所必需的。然后我们证明,p14ARF的缺失以p53依赖的方式促进生长,但几乎没有致瘤作用。相比之下,抑制p16INK4A的表达不影响细胞增殖,但与p53缺失协同作用以加速生长并导致转化。我们的结果阐明了人类INK4A基因在正常生长和致瘤生长中的功能。